NOVARTIS AG Pricing & Demo

Are you from this Company?
NOVARTIS AG
Write a Review
Basel, Switzerland
1996
$10BN to $50BN
Enterprise
78 Likes
84 Buyers Negotiating
Summary
No Summary And Details

Popular Comparisons

Discussions

Strengths
  • +11
    Product Branding
  • +10
    Unique and Compelling Differentiating Factor
  • +6
    Anticholinergic
  • +13
    Capsule
  • +12
    Tablet
  • +10
    Anticholinergics
  • +8
    Branded Drug
  • +9
    COMT-Inhibitors
  • +6
    Levodopa/cardbidopa therapy
  • +11
    Others
  • +9
    Product Differentiation and Impact on Customer Value
  • +5
    COMT-Inhibitor
  • +13
    Dopamine Receptor Agonist
  • +12
    Levodopa cardbidopa therapy
  • +14
    MAO-Inhibitor
  • +7
    Other
  • +5
    Patch
  • +14
    Solution
  • +7
    Dopamine Receptor Agonists
  • +9
    Generic Drug
Cautions
  • -8
    MAO-Inhibitors
  • -7
    Breadth and Depth of Product Offerings
  • -8
    Focus on Product Innovation
  • -6
    Product Features and Functionality
  • -7
    R&D Expenditure
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup
logo-360
  • saved

    You haven’t saved anything yet

    To save, search for Vendors by
    Name or Category, then tap the heart